Page last updated: 2024-08-23

alovudine and Cancer of Larynx

alovudine has been researched along with Cancer of Larynx in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (66.67)29.6817
2010's1 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Been, LB; Elsinga, PH; Hoekstra, HJ; Jager, PL; Suurmeijer, AJ; van der Laan, BF1
Agool, A; Been, LB; Burlage, FR; Cobben, DC; Dierckx, RA; Elsinga, PH; Glaudemans, AW; Holter, JL; Slart, RH; Thorp, KK; Vellenga, E1
Cobben, DC; Elsinga, PH; Hoekstra, HJ; Jager, PL; Maas, B; Suurmeijer, AJ; Vaalburg, W; van der Laan, BF1

Other Studies

3 other study(ies) available for alovudine and Cancer of Larynx

ArticleYear
[18F]FLT-PET and [18F]FDG-PET in the evaluation of radiotherapy for laryngeal cancer.
    Oral oncology, 2009, Volume: 45, Issue:12

    Topics: Aged; Aged, 80 and over; Dideoxynucleosides; Feasibility Studies; Fluorodeoxyglucose F18; Humans; Laryngeal Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prognosis; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity

2009
Effect of radiotherapy and chemotherapy on bone marrow activity: a 18F-FLT-PET study.
    Nuclear medicine communications, 2011, Volume: 32, Issue:1

    Topics: Adult; Aged; Bone Marrow; Dideoxynucleosides; Drug-Related Side Effects and Adverse Reactions; Feasibility Studies; Humans; Laryngeal Neoplasms; Male; Neoplasms, Germ Cell and Embryonal; Positron-Emission Tomography; Radiotherapy; Retrospective Studies; Testicular Neoplasms

2011
18F-FLT PET for visualization of laryngeal cancer: comparison with 18F-FDG PET.
    Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2004, Volume: 45, Issue:2

    Topics: Aged; Biopsy; Carcinoma, Squamous Cell; Dideoxynucleosides; Feasibility Studies; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Laryngeal Neoplasms; Larynx; Male; Neoplasm Recurrence, Local; Prospective Studies; Radiopharmaceuticals; Tomography, Emission-Computed

2004